STOCK TITAN

[8-K] ORTHOPEDIATRICS CORP Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Orthopedics Corp (KIDS) disclosed that it has prepared preliminary net revenue estimates but these figures are subject to completion of the company's audit and may change. The company warns that results for the third quarter and for the full year could differ materially from the preliminary estimates and cautions readers not to place undue reliance on forward-looking statements. Investors are directed to the Risk Factors discussion in the company's Annual Report filed with the SEC for factors that could cause actual results to diverge. The company also states it will not update these forward-looking estimates publicly unless required by law.

Orthopedics Corp (KIDS) ha comunicato di aver predisposto delle stime preliminari di utile netto, ma tali cifre sono soggette al completamento della revisione contabile e potrebbero cambiare. L'azienda avverte che i risultati del terzo trimestre e dell'anno intero potrebbero differire in modo sostanziale dalle stime preliminari e avverte i lettori di non fare affidamento indebito su dichiarazioni previsionali. Gli investitori sono indirizzati alla discussione sui Fattori di rischio nel Rapporto Annuale depositato presso la SEC per i fattori che potrebbero causare una divergenza tra i risultati effettivi. L'azienda inoltre afferma che non aggiornerà pubblicamente queste stime prospettiche se la legge non lo richiede.

Orthopedics Corp (KIDS) ha informado que ha preparado estimaciones preliminares de ingresos netos, pero estas cifras están sujetas a la finalización de la auditoría de la empresa y pueden cambiar. La empresa advierte que los resultados del tercer trimestre y del año completo podrían diferir de manera sustancial de las estimaciones preliminares y advierte a los lectores que no deben confiar indebididamente en declaraciones prospectivas. Los inversores deben remitirse a la discusión de Factores de Riesgo en el Informe Anual presentado ante la SEC para los factores que podrían hacer que los resultados reales diverjan. La empresa también señala que no actualizará públicamente estas estimaciones prospectivas a menos que la ley lo exija.

Orthopedics Corp (KIDS)은 감사의 완료에 따라 다를 수 있는 예비 순매출 추정치를 준비했다고 공개했다. 이 수치는 감사 완료에 따라 변경될 수 있다. 회사는 3분기연간 실적이 예비 추정치와 실질적으로 다를 수 있음을 경고하고, 미래 지향적 진술에 무리한 의존을 하지 말 것을 독자들에게 주의시킨다. 투자자들은 실제 결과가 차이날 수 있는 요인에 대해 SEC에 제출된 연차보고서의 리스크 요인 섹션을 참조하라고 안내되어 있다. 또한 법이 요구하지 않는 한 이러한 미래 지향적 추정치를 공개적으로 업데이트하지 않을 것이라고 회사는 밝혔다.

Orthopedics Corp (KIDS) a déclaré avoir préparé des estimations préliminaires du chiffre d’affaires net, mais ces chiffres restent soumis à l’achèvement de l’audit de la société et peuvent changer. La société avertit que les résultats du troisième trimestre et de l’exercice complet pourraient différer de manière significative des estimations préliminaires et met en garde les lecteurs de ne pas accorder une confiance excessive aux déclarations prospectives. Les investisseurs sont dirigés vers la discussion des Facteurs de Risque dans le Rapport Annuel déposé auprès de la SEC pour les facteurs qui pourraient entraîner une divergence des résultats réels. La société déclare également qu’elle ne mettra pas à jour publiquement ces estimations prospectives, sauf si la loi l’exige.

Orthopedics Corp (KIDS) gab bekannt, dass es vorläufige Nettoumsatz-Schätzungen vorbereitet hat, aber diese Zahlen der Fertigstellung der Prüfung unterliegen und sich ändern können. Das Unternehmen warnt, dass die Ergebnisse des dritten Quartals und des Gesamtjahres erheblich von den vorläufigen Schätzungen abweichen könnten, und rät den Lesern, sich nicht übermäßig auf zukunftsgerichtete Aussagen zu verlassen. Anleger werden auf die Risikofaktoren-Diskussion im Jahresbericht verwiesen, der bei der SEC eingereicht wurde, für Faktoren, die dazu führen könnten, dass tatsächliche Ergebnisse abweichen. Das Unternehmen erklärt außerdem, dass es diese zukunftsgerichteten Schätzungen nicht öffentlich aktualisieren wird, es sei denn, gesetzlich vorgeschrieben.

Orthopedics Corp (KIDS) كشفت أنها أعددت تقديرات مبدئية للإيرادات الصافية لكنها تخضع لاستكمال تدقيق الشركة وقد تتغير. تحذر الشركة من أن نتائج الربع الثالث وللسنة الكاملة قد تختلف مادياً عن التقديرات المبدئية وتحث القراء على عدم الاعتماد بشكل مفرط على البيانات المستقبلية. يُطلب من المستثمرين الرجوع إلى مناقشة عوامل الخطر في التقرير السنوي المقدم إلى هيئة الأوراق المالية والبورصات (SEC) من أجل العوامل التي قد تجعل النتائج الفعلية تتباين. كما تنص الشركة على أنها لن تقوم بتحديث هذه التقديرات المستقبلية علنًا إلا إذا فرض القانون ذلك.

Orthopedics Corp (KIDS) 已披露已准备好< b>初步净收入估算,但这些数字需要完成公司审计后才能确定,可能会发生变动。公司警告第三季度及全年业绩可能与初步估算存在实质性差异,并提醒读者不要对前瞻性陈述过分依赖。投资者请参考公司提交给SEC的年度报告中的风险因素讨论,以了解可能导致实际结果分歧的因素。公司还表示,除非法律要求,否则不会公开更新这些前瞻性估算。

Positive
  • Preliminary estimates disclosed, indicating transparency about current revenue expectations
Negative
  • Estimates may change materially for the third quarter and the full year because they are subject to audit

Orthopedics Corp (KIDS) ha comunicato di aver predisposto delle stime preliminari di utile netto, ma tali cifre sono soggette al completamento della revisione contabile e potrebbero cambiare. L'azienda avverte che i risultati del terzo trimestre e dell'anno intero potrebbero differire in modo sostanziale dalle stime preliminari e avverte i lettori di non fare affidamento indebito su dichiarazioni previsionali. Gli investitori sono indirizzati alla discussione sui Fattori di rischio nel Rapporto Annuale depositato presso la SEC per i fattori che potrebbero causare una divergenza tra i risultati effettivi. L'azienda inoltre afferma che non aggiornerà pubblicamente queste stime prospettiche se la legge non lo richiede.

Orthopedics Corp (KIDS) ha informado que ha preparado estimaciones preliminares de ingresos netos, pero estas cifras están sujetas a la finalización de la auditoría de la empresa y pueden cambiar. La empresa advierte que los resultados del tercer trimestre y del año completo podrían diferir de manera sustancial de las estimaciones preliminares y advierte a los lectores que no deben confiar indebididamente en declaraciones prospectivas. Los inversores deben remitirse a la discusión de Factores de Riesgo en el Informe Anual presentado ante la SEC para los factores que podrían hacer que los resultados reales diverjan. La empresa también señala que no actualizará públicamente estas estimaciones prospectivas a menos que la ley lo exija.

Orthopedics Corp (KIDS)은 감사의 완료에 따라 다를 수 있는 예비 순매출 추정치를 준비했다고 공개했다. 이 수치는 감사 완료에 따라 변경될 수 있다. 회사는 3분기연간 실적이 예비 추정치와 실질적으로 다를 수 있음을 경고하고, 미래 지향적 진술에 무리한 의존을 하지 말 것을 독자들에게 주의시킨다. 투자자들은 실제 결과가 차이날 수 있는 요인에 대해 SEC에 제출된 연차보고서의 리스크 요인 섹션을 참조하라고 안내되어 있다. 또한 법이 요구하지 않는 한 이러한 미래 지향적 추정치를 공개적으로 업데이트하지 않을 것이라고 회사는 밝혔다.

Orthopedics Corp (KIDS) a déclaré avoir préparé des estimations préliminaires du chiffre d’affaires net, mais ces chiffres restent soumis à l’achèvement de l’audit de la société et peuvent changer. La société avertit que les résultats du troisième trimestre et de l’exercice complet pourraient différer de manière significative des estimations préliminaires et met en garde les lecteurs de ne pas accorder une confiance excessive aux déclarations prospectives. Les investisseurs sont dirigés vers la discussion des Facteurs de Risque dans le Rapport Annuel déposé auprès de la SEC pour les facteurs qui pourraient entraîner une divergence des résultats réels. La société déclare également qu’elle ne mettra pas à jour publiquement ces estimations prospectives, sauf si la loi l’exige.

Orthopedics Corp (KIDS) gab bekannt, dass es vorläufige Nettoumsatz-Schätzungen vorbereitet hat, aber diese Zahlen der Fertigstellung der Prüfung unterliegen und sich ändern können. Das Unternehmen warnt, dass die Ergebnisse des dritten Quartals und des Gesamtjahres erheblich von den vorläufigen Schätzungen abweichen könnten, und rät den Lesern, sich nicht übermäßig auf zukunftsgerichtete Aussagen zu verlassen. Anleger werden auf die Risikofaktoren-Diskussion im Jahresbericht verwiesen, der bei der SEC eingereicht wurde, für Faktoren, die dazu führen könnten, dass tatsächliche Ergebnisse abweichen. Das Unternehmen erklärt außerdem, dass es diese zukunftsgerichteten Schätzungen nicht öffentlich aktualisieren wird, es sei denn, gesetzlich vorgeschrieben.

0001425450FALSE00014254502023-03-112023-03-11


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
______________________

Date of Report (Date of earliest event reported): October 9, 2025
OrthoPediatrics Corp.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
001-3824226-1761833
(Commission File Number)(I.R.S. Employer Identification Number)
2850 Frontier Drive
Warsaw, Indiana
46582
(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (574) 268-6379
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.00025 par value per shareKIDSNasdaq Global Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act (17 CFR 230.405) or Rule 12b-2 under the Exchange Act (17 CFR 240.12b-2).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ¨



Item 2.02. Results of Operations and Financial Condition.

On October 9, 2025, OrthoPediatrics Corp. (the "Company”) issued a press release announcing its preliminary unaudited net revenue for the third quarter ended September 30, 2025, revised financial guidance for the year ending December 31, 2025, and provided business updates. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

The information in this Item 2.02, including the information incorporated by reference herein from Exhibit 99.1, is furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

The financial information set forth in this Form 8-K reflects the Company's current preliminary net revenue estimates, is subject to the completion of its audit process, and is subject to change. The Company's results for the third quarter ended September 30, 2025 could differ materially from the preliminary estimates provided in this form 8-K. The Company's net revenue for the full year ending December 31, 2025 could also differ materially from the forecasted amounts. You are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date of this Form 8-K. You should refer to the “Risk Factors” section of the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 5, 2025, as updated and supplemented by our other SEC reports filed from time to time, for a discussion of important factors that may cause our actual results and net revenue to differ materially from those expressed or implied by these forward-looking statements. Given these risks, uncertainties and other factors, many of which are beyond our control, you are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly release the results of any revision or update of the forward-looking statements, except as required by law.

Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
Exhibit No.Description
99.1
Orthopediatrics Corp. Revenue and Revised 2025 Guidance dated October 2025
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
* * * * * *



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
OrthoPediatrics Corp.
Date:   October 9, 2025By:/s/ Daniel J. Gerritzen
Daniel J. Gerritzen,
General Counsel and Secretary


- 2 -

FAQ

What did Orthopedics Corp (KIDS) disclose in this 8-K?

The company disclosed preliminary net revenue estimates and said those estimates are subject to completion of its audit and may change.

Are the preliminary revenue estimates final for KIDS?

No. The estimates are preliminary, subject to the completion of the audit process, and could differ materially.

Will KIDS update these forward-looking estimates publicly?

The company stated it will not publicly update the estimates except as required by law.

Where should investors look for risks that could affect KIDS results?

Investors should refer to the Risk Factors section of the company's Annual Report filed with the SEC for factors that may cause actual results to differ.
Orthopedia

NASDAQ:KIDS

KIDS Rankings

KIDS Latest News

KIDS Latest SEC Filings

KIDS Stock Data

453.83M
16.87M
32.71%
71.29%
4.85%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
WARSAW